How do I find out if I qualify for a nsclc (advanced non-small cell lung cancer) study in Illinois?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Illinois to take part?

Not necessarily. These studies have a site in Illinois, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a nsclc (advanced non-small cell lung cancer) trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Illinois

NSCLC (Advanced Non-small Cell Lung Cancer) clinical trials in Illinois

We’re tracking 76 recruiting nsclc (advanced non-small cell lung cancer) studies with a site in Illinois — including Phase 1, Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.

Recruiting studies in Illinois

NCT07389239RecruitingPhase 1/Phase 2
Immunotherapy for ovarian cancer and other advanced tumors
This study tests an immunotherapy treatment for people with advanced solid tumors, including ovarian cancer, sarcoma, prostate, breast, lung, and others. It is designed for tumors that show a specific marker called NY-ESO-1, and aims to see if the treatment can help shrink or control the cancer.
Chicago, IllinoisAges 18 years+
NCT03816345RecruitingPhase 1
Nivolumab for advanced cancer with autoimmune disease
This trial tests whether the immunotherapy drug nivolumab can safely treat advanced cancer in people who also have an autoimmune disease like rheumatoid arthritis, lupus, or multiple sclerosis. It aims to find out if the drug may help control cancer while managing their autoimmune condition.
Chicago, IllinoisAges 18 years+
NCT06581432RecruitingPhase 2
Zongertinib for advanced cancers with HER2 changes
This trial tests an experimental pill called zongertinib for people with different types of advanced solid tumors that have a specific genetic change called HER2. It's a treatment option when other therapies haven't worked, and it may help shrink or slow the cancer.
Arlington Heights, IllinoisAges 18 years+
NCT05417594RecruitingPhase 1/Phase 2
Targeted drug study for advanced cancers with genetic changes
This Phase 1/2 study tests AZD9574 alone or with other cancer treatments in people with advanced solid tumors. It focuses on cancers with specific DNA repair gene changes (like BRCA1/2) or other matching tumor features, and aims to see if the treatment can shrink tumors and improve outcomes.
Chicago, IllinoisAges 18–130

NSCLC (Advanced Non-small Cell Lung Cancer) trials by city in Illinois

Chicago

Where these studies are running in Illinois

Institutions with a site for the recruiting nsclc (advanced non-small cell lung cancer) studies listed above.

Illinois Cancer Specialists
Northwestern University
Research Site
University of Chicago Comprehensive Cancer Center
University of Chicago Medicine Comprehensive Cancer Center

What taking part in a nsclc (advanced non-small cell lung cancer) study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

NSCLC (Advanced Non-small Cell Lung Cancer) trials in other states

Common questions

Are there nsclc (advanced non-small cell lung cancer) clinical trials in Illinois?: Yes. We're currently tracking 76 recruiting nsclc (advanced non-small cell lung cancer) studies with a site in Illinois, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a nsclc (advanced non-small cell lung cancer) study in Illinois?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Illinois to take part?: Not necessarily. These studies have a site in Illinois, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a nsclc (advanced non-small cell lung cancer) trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New nsclc (advanced non-small cell lung cancer) studies open in Illinois regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.